Your browser doesn't support javascript.
loading
Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.
Zauner, Roland; Wimmer, Monika; Atzmueller, Sabine; Proell, Johannes; Niklas, Norbert; Ablinger, Michael; Reisenberger, Manuela; Lettner, Thomas; Illmer, Julia; Dorfer, Sonja; Koller, Ulrich; Guttmann-Gruber, Christina; Hofbauer, Josefina Piñón; Bauer, Johann W; Wally, Verena.
Afiliação
  • Zauner R; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Wimmer M; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Atzmueller S; Center for Medical Research, Medical Faculty, Johannes-Kepler-University, 4020 Linz, Austria.
  • Proell J; Center for Medical Research, Medical Faculty, Johannes-Kepler-University, 4020 Linz, Austria.
  • Niklas N; Red Cross Transfusion Service of Upper Austria, 4020 Linz, Austria.
  • Ablinger M; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Reisenberger M; Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Lettner T; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Illmer J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Dorfer S; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Koller U; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Guttmann-Gruber C; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Hofbauer JP; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Bauer JW; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Wally V; Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Cancers (Basel) ; 15(13)2023 Jun 22.
Article em En | MEDLINE | ID: mdl-37444397
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article